Doximity downgraded to Hold from Buy at Canaccord | Nasdaq

4 days ago · Canaccord downgraded Doximity (DOCS) to Hold from Buy with a price target of $60, up from $40. The firm recognizes that Doximity is "currently executing flawlessly," beating …

CouponFollow Extension

$60
OFF

Doximity Downgraded To Hold From Buy At Canaccord | Nasdaq

1 week from now

4 days ago · Canaccord downgraded Doximity (DOCS) to Hold from Buy with a price target of $60, up from $40. The firm recognizes that Doximity is "currently executing flawlessly," beating …

nasdaq.com

30%
OFF

Doximity Downgraded At Canaccord After Recent Rally - MSN

1 week from now

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect …

msn.com

19%
OFF

Canaccord Genuity Downgrades Doximity (DOCS) - MSN

1 week from now

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to Hold. Analyst Price Forecast Suggests 28.19% Downside …

msn.com

22%
OFF

Canaccord Cautious On Doximity Stock As Robust Growth Already …

1 week from now

4 days ago · DOCS. -5.22%. On Wednesday, Canaccord Genuity adjusted its stance on Doximity Inc (NYSE: DOCS), downgrading the stock from Buy to Hold while raising the price target to …

investing.com

1%
OFF

Doximity Falls After Brokerage Downgrades To 'hold' - TradingView

1 week from now

3 days ago · Nov 13, 202408:31 PST. DOCS. ** Telehealth company Doximity's DOCS shares fall 4.1% to $55.66. ** Canaccord Genuity downgrades company's shares to "hold" from "buy". ** …

tradingview.com

$48.14
OFF

Doximity (DOCS) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

2 days ago · According to the 17 analysts' twelve-month price targets for Doximity, the average price target is $48.14. The highest price target for DOCS is $75.00, while the lowest price …

marketbeat.com

$30
OFF

Canaccord Genuity Downgrades Doximity To Hold From Buy, …

1 week from now

-- Doximity has an average rating of outperform and price targets ranging from $30 to $75, according to analysts polled by Capital IQ. Price: 56.55, Change: -1.50, Percent Change: -2.58 ...

marketscreener.com

$49
OFF

Doximity Price Target Raised To $49 From $35 At Truist

1 week from now

2 days ago · Doximity downgraded to Hold from Buy at Canaccord Doximity price target raised to $75 from $52 at Barclays Nvidia trades on Dow for first time, Rivian reports downbeat Q3: …

nasdaq.com

$60.00
OFF

Canaccord Genuity Downgrades Doximity Inc (DOCS) To Hold

1 week from now

4 days ago · Canaccord Genuity analyst Richard Close downgraded Doximity Inc (NYSE: DOCS) from Buy to Hold with a price target of $60.00 ... This is a premium only article. To continue …

streetinsider.com

$40.00
OFF

Doximity (DOCS) Receives A Buy From Canaccord Genuity

1 week from now

Jun. 7, 2023, 10:35 AM. In a report released today, Richard Close from Canaccord Genuity reiterated a Buy rating on Doximity (DOCS – Research Report), with a price target of $40.00. …

businessinsider.com

$75
OFF

Doximity Upgraded To Equal Weight From Underweight At Morgan …

1 week from now

3 days ago · Doximity downgraded to Hold from Buy at Canaccord; Doximity price target raised to $75 from $52 at Barclays; Nvidia trades on Dow for first time, Rivian reports downbeat Q3: …

nasdaq.com

$40
OFF

Canaccord Genuity Downgrades Doximity To Hold, Raises Price …

1 week from now

4 days ago · Canaccord Genuity analyst Richard Close downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $40 to $60.

sahmcapital.com

FAQs about Doximity downgraded to Hold from Buy at Canaccord | Nasdaq Coupon?

Is Doximity (Docs) a good stock to buy in 2024?

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to Hold. Analyst Price Forecast Suggests 28.19% Downside As of October 22, 2024, the average one-year price target for Doximity is $37.96/share. The forecasts range from a low of $19.19 to a high of $54.60. ...

Should you buy Doximity (Docs)?

Play(1min) ozgurdonmaz/E+ via Getty Images Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high expectations for the online medical platform. ...

Why did Genuity downgrade Doximity (Docs)?

C anaccord Genuity on Wednesday downgraded Doximity (NYSE: DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high expectations for the online medical platform. ...

Does Doximity (Docs) have a good Q2 performance?

Acknowledging Doximity’s (DOCS) Q2 beat and better-than-expected guidance, Canaccord notes that the company is delivering record-adjusted EBITDA margins and generating strong free cash flow. ...

Should you buy Seeking Alpha Doximity (Docs) stock?

Do Not Sell My Personal Information Market Data Sources © 2024 Seeking Alpha Doximity (DOCS) stock falls as Canaccord Genuity downgrades it to hold from buy, on high expectations reflected in its shares after earnings-led rally. Read more here. ...

Is Doximity a good stock to buy?

Acknowledging Doximity’s (NYSE:DOCS) Q2 beat and better-than-expected guidance, Canaccord notes that the company is delivering record-adjusted EBITDA margins and generating strong free cash flow. ...